Gossamer Bio GOSS - Options Chain | ADVFN

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Gossamer Bio Inc (GOSS)
Gossamer Bio Inc (GOSS) Options

Gossamer Bio Inc (GOSS)

0.694

-0.036

(-4.93%)

Closed May 17 4:00PM

Delayed by 15 minutes

0.6939

-0.0001

(-0.01%)

After Hours: 7:58PM

Delayed by 15 minutes

GOSS Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
0.50	0.20	1.00	0.00	0.60	0.00	0.00 %	0	0	-
1.00	0.10	0.15	0.10	0.125	0.00	0.00 %	0	250	-
1.50	0.04	0.05	0.04	0.045	0.00	0.00 %	0	4	-
2.00	0.00	0.50	0.00	0.00	0.00	0.00 %	0	0	-
3.00	0.00	0.50	0.00	0.00	0.00	0.00 %	0	0	-

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
0.50	0.04	0.30	0.04	0.17	0.00	0.00 %	0	39	-
1.00	0.25	0.35	0.00	0.30	0.00	0.00 %	0	0	-
1.50	0.60	1.45	0.00	1.025	0.00	0.00 %	0	0	-
2.00	1.15	1.95	0.00	1.55	0.00	0.00 %	0	0	-
3.00	2.10	2.70	0.00	2.40	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.67M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.22M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.34M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.73B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.3M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.2M

FlippinNDippin

FlippinNDippin 1 month ago

Took a starter here. GLTA

Monksdream

Monksdream 2 months ago

glenn1919

glenn1919 2 months ago

GOSS..........................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 months ago

GOSS..................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

glenn1919

glenn1919 3 months ago

GOSS......................................https://stockcharts.com/h-sc/ui?s=GOSS&p=W&b=5&g=0&id=p86431144783

Monksdream

Monksdream 3 months ago

Monksdream

Monksdream 8 months ago

GOSS new 52 week low

Monksdream

Monksdream 8 months ago

GOSS new 52 week low

Monksdream

Monksdream 8 months ago

GOSS new 52 week low

Dutch4

Dutch4 1 year ago

hippityhop

hippityhop 1 year ago

Institutionals shorting this unmercilessly. Three trades totalling 2.4M total shares bought at 4 pm. @ .20 cent profit a share come to $468k.

hippityhop

hippityhop 1 year ago

This is a 100/200 percenter in next 3 months, buy this now or weep later!!

crudeoil24

crudeoil24 2 years ago

Raymond James Initiates Coverage On Gossamer Bio with Outperform Rating, Announces Price Target of $19
7:13 am ET April 18, 2022 (Benzinga) Print
Raymond James analyst Timur Ivannikov initiates coverage on Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $19.

Latest Ratings for GOSS DateFirmActionFromTo

Nov 2021SVB LeerinkMaintainsOutperform Aug 2021SVB LeerinkMaintainsOutperform Mar 2021HC Wainwright & Co.ReiteratesBuy

crudeoil24

crudeoil24 2 years ago

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. The Company's product candidates include Seralutinib (GB002), GB004, GB5121 and GB7208. GB002 is an inhaled, small molecule, platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R) and c-KIT inhibitor in development for the treatment of pulmonary arterial hypertension (PAH). GB004 is a gut-targeted, oral small molecule being developed for the treatment of inflammatory bowel disease (IBD). GB5121 is an oral, irreversible, covalent, small molecule inhibitor of Bruton’s Tyrosine Kinase (BTK), in clinical development for the treatment of primary central nervous system lymphoma (PCNSL). GB7208 is an oral, small molecule, BTK inhibitor in preclinical development for the treatment of multiple sclerosis (MS).

All Things Considered

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions